期刊文献+

PRDM9多态性与慢性粒细胞白血病的关联性研究

The association study between PRDM9 polymorphisms and chronic myelogenous leukemia
下载PDF
导出
摘要 目的探究PRDM9多态性与慢性粒细胞白血病(CML)遗传易感性的关系。方法应用PCR直接测序技术与DNA单克隆测序技术,对116名Ph染色体及BCR-ABL融合基因阳性CML患者(CML组)和111名健康对照人群(对照组)的PRDM9多态性做DNA序列测定分析;对比CML患者与健康人群的PRDM9多态性分布差异,并通过卡方检验来探究二者之间的关联性。结果在对照组中共发现了7种PRDM9等位基因,其中已命名的有PRDM9-A、B、C、L3及L7,另外2个为新等位基因,分别命名为X1和X2。CML组中共发了10种PRDM9等位基因,除5个已命名等位基因与对照组一样,还发现了5个新等位基因X1、X2、X5、X12及X13。CML组与对照组中PRDM9-A及B等位基因分布为分别为68.10%vs 83.78%,19.40%vs 9.91%(P<0.01),AA基因型分布为41.38%vs 71.17%,AB基因型分布为33.62%vs 15.32%(P<0.01)。此外,PRDM9基因多态性分布在中国汉族与欧洲及非洲人群中存在明显差异(P<0.01)。结论 PRDM9多态性与CML具有关联性,A及AA是CML发生的保护等位基因及基因型,B及AB是CML发生的易感等位基因及基因型。PRDM9基因多态性分布具有人群特异性。 Objective To study the association between PRDM9 polymorphisms and chronic myelogenous leukemia.Methods By using the PCR-based direct sequencing technique and DNA monoclonal sequencing method,PRDM9 polymorphisms in 166 Ph chromosome positive and BCR-ABL positive CML patients and 111 healthy controls were sequenced. Comparative analysis of PRDM9 polymorphism distribution differences between patient and control groups was conducted using the chi--square test to explore the correlation. Results Seven PRDM9 alleles were identified from 111 controls,of which 5 alleles had already been named,PRDM9-A,B,C,L3 and L7. The other 2 alleles were confirmed as new alleles,named X1 and X2,respectively. Ten PRDM9 allele were detected in 116 CML cases,among which the 5 existent alleles were the same as in the control group. Five new alleles,besides the X1,X2,the rest were named as X5,X12 and X13,respectively. The A and B alleles distribution in CML group and the control group were 68. 10% vs 68. 10%,19. 40% vs 9. 91%( P〈0. 01).The AA genotype distribution were 41. 38% vs 71. 17%( P〈0. 01). In addition,PRDM9 genetic polymorphism distribution was significantly different among Han Chinese,European and African( P〈0. 05). Conclusion For the first time,this study discovered the association of PRDM9 polymorphisms with CML. A and AA are protective factors to resist the occurrence of CML,while B and AB are susceptible factors to the occurrence of CML. This study also confirmed that the distribution of PRDM9 possesses population specificities.
出处 《中国输血杂志》 CAS 北大核心 2016年第6期584-588,共5页 Chinese Journal of Blood Transfusion
基金 国家重大科学研究计划("973")项目(2009CB522401)
关键词 PRDM9 慢性粒细胞白血病 基因多态性 遗传易感性 保护基因 PRDM9(PR domain zinc finger protein 9 coding gene) chronic myelogenous leukemia polymorphism association
  • 相关文献

参考文献19

  • 1Wang Z,Zen W,Meng F,et al.Chronic myeloid leukemia with variation of translocation at(Ph)[ins(22;9)(q11;q21q34)]:a case report.Int J Clin Exp Pathol,2015,8(10):13707-13710.
  • 2卞寿庚,急性白血病.见张之南,沈悌.血液病诊断及疗效标准(第三版).北京:科学出版社,2007:103-121.
  • 3Naumann S,Decker HJ.Genesis of variant Philadelphia chromosome translocations in chronic myelocytic leukemia.Cancer Genet Cytogenet,2003,147(1):18-22.
  • 4吴学琼,李春蕊,田野,孙汉英,刘文励.定量监测慢性粒细胞白血病患者治疗过程中BCR-ABL融合基因转录本水平变化的临床意义[J].内科急危重症杂志,2010,16(4):190-192. 被引量:4
  • 5Bennour A,Sennana H,Laatiri MA,et al.Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia:genesis and deletion of derivative chromosome9.Cancer Genet Cytogenet,2009,194(1):30-37.
  • 6Yaghmaie M,Ghaffari SH,Ghavamazdeh A,et al.Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic yeloid leukemia.Arch Iran Med,2008,11(3):247-251.
  • 7Naka K,Hoshii T,Tadokoro Y,et al.Molecular pathology of tumor-initiating cells:lessons from Philadelphia chromosome-positive leukemia.Pathol Int,2011,61(9):501-508.
  • 8Jabbour E,Kantarjian H,Jones D,et al.Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinibmesylate.Leukemia,2006,20(10):1767-1773.
  • 9White HE,Matejtschuk P,Rigsby P,et al.Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.Blood,2010,116(22):e111-117.
  • 10Miyamoto T,Koh E,Sakugawa N,et al.Two single nucleotide polymorphisms in PRDM9(MEISETZ)gene may be a genetic risk factor for Japanese patients with azoospermia by meiotic arrest.J Assist Reprod Genet,2008,25(11-12):553-557.

二级参考文献6

  • 1Sooknanan R, Malek L, Wang XH, et al. Detection and direct sequence indentification of BCR/ABL mRNA in Ph+ chronic myeloid leukemia. Exp Hematol, 1993,21 : 1719.
  • 2Beillard E, Pallisgaard N, Van der Velden VH, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using " real-time" quantitative reverse-transctiptase polyrnerase chain reaction (RQ-PCR)-a Europe against cancer program. Leukemia, 2003,17 : 2474.
  • 3Druker BJ, Lydon NB. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest,2000,105;3.
  • 4Sahay T, Schiller CA. Monitoring minimal residual disease in patients with chronic myeloid leukemia after treatment with tyrosine kinase inhibitors. Curr Opin Hematol, 2008,15 : 134.
  • 5Carrasco M, Sureda A, Martinez C, et al. Prognostic factors in fluencing feasibility of cytogenetic and molecular analysis in leu kapheresis products in chronic myelogenous leukemia patients. Ann hematol,2002,81:710.
  • 6王椿,秦尤文.慢性髓细胞白血病的诊断方法[J].内科急危重症杂志,2009,15(2):58-61. 被引量:1

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部